Dickkopf-1 Promotes Angiogenesis and is a Biomarker for Hepatic Stem Cell-like Hepatocellular Carcinoma.

Dickkopf-1 Promotes Angiogenesis and is a Biomarker for Hepatic Stem Cell-like Hepatocellular Carcinoma.
复制标题

DOI:
10.3390/ijms23052801
复制
发表时间:
2022-03-03
影响因子:
5.6
通讯作者:
Kaneko S
Kaneko S
中科院分区:
生物学2区
文献类型:
--
作者:
Suda T;Yamashita T;Sunagozaka H;Okada H;Nio K;Sakai Y;Yamashita T;Mizukoshi E;Honda M;Kaneko S

文献摘要

参考文献

被引文献

相似文献

癌症干性因其导致的恶性程度和不良预后而引起关注。我们先前证明,肝干细胞样肝细胞癌(HpSC - HCC)与高血管侵犯和不良预后相关。Dickkopf - 1(DKK - 1)是一种Wnt信号调节因子,在HpSC - HCC中高表达。在此,我们评估了血清DKK - 1的诊断和预后潜力。与205例慢性肝病患者相比,391例肝细胞癌患者的血清DKK - 1水平显著升高。受试者工作特征曲线分析显示,诊断肝细胞癌以及预测3年生存率的DKK - 1最佳临界值分别为262.2 pg/mL和365.9 pg/mL。血清DKK - 1水平高的肝细胞癌患者预后不良。我们评估了抗DKK - 1抗体治疗对体内肿瘤生长的影响,以及重组DKK - 1对体外细胞增殖、侵袭和血管生成的影响。DKK - 1敲低减少了癌细胞的增殖、迁移和侵袭。DKK - 1补充促进了体外血管生成;这种作用被抗DKK - 1抗体消除。抗DKK - 1抗体与Huh7细胞共同注射抑制了它们在NOD/SCID小鼠体内的生长。因此,DKK - 1促进肝细胞癌细胞的增殖、迁移和侵袭,并激活血管内皮细胞的血管生成。DKK - 1是肝细胞癌的一种预后生物标志物,也是一种用于靶向治疗的功能分子。
Cancer stemness evinces interest owing to the resulting malignancy and poor prognosis. We previously demonstrated that hepatic stem cell-like hepatocellular carcinoma (HpSC-HCC) is associated with high vascular invasion and poor prognosis. Dickkopf-1 (DKK-1), a Wnt signaling regulator, is highly expressed in HpSC-HCC. Here, we assessed the diagnostic and prognostic potential of serum DKK-1. Its levels were significantly higher in 391 patients with HCC compared with 205 patients with chronic liver disease. Receiver operating characteristic curve analysis revealed the optimal cutoff value of DKK-1 to diagnose HCC and predict the 3-year survival as 262.2 and 365.9 pg/mL, respectively. HCC patients with high-serum DKK-1 levels showed poor prognosis. We evaluated the effects of anti-DKK-1 antibody treatment on tumor growth in vivo and of recombinant DKK-1 on cell proliferation, invasion, and angiogenesis in vitro. DKK-1 knockdown decreased cancer cell proliferation, migration, and invasion. DKK-1 supplementation promoted angiogenesis in vitro; this effect was abolished by an anti-DKK-1 antibody. Co-injection of the anti-DKK-1 antibody with Huh7 cells inhibited their growth in NOD/SCID mice. Thus, DKK-1 promotes proliferation, migration, and invasion of HCC cells and activates angiogenesis in vascular endothelial cells. DKK-1 is a prognostic biomarker for HCC and a functional molecule for targeted therapy.
DOI: 10.1186/1476-4598-12-157
发表时间: 2013-12-10
期刊: Molecular cancer
影响因子: 37.3
作者:
Chen L;Li M;Li Q;Wang CJ;Xie SQ
通讯作者: Xie SQ
DOI: 10.1038/34848
发表时间: 1998-01-22
期刊: NATURE
影响因子: 64.8
作者:
Glinka, A;Wu, W;Niehrs, C
通讯作者: Niehrs, C
DOI: 10.1007/s12032-014-0966-8
发表时间: 2014-07-01
期刊: MEDICAL ONCOLOGY
影响因子: 3.4
作者:
Huang, Yan;Yang, Xinrong;Qin, Wenxin
通讯作者: Qin, Wenxin
DOI: 10.1080/13543784.2021.1948532
发表时间: 2021-07-01
影响因子: 6.1
作者:
Rizzo, Alessandro;Dadduzio, Vincenzo;Brandi, Giovanni
通讯作者: Brandi, Giovanni
DOI: 10.1016/j.jhep.2014.11.005
发表时间: 2015-04-01
影响因子: 25.7
作者:
Pote, Nicolas;Cauchy, Franois;Paradis, Valerie
通讯作者: Paradis, Valerie